Reimagining Brain Drug Delivery: Mechanistic and Translational Advances in Carbon Nanotube Nanomedicine
Journal of Applied Toxicology · 2026-07 · 46 (7) · 2250-2274
DOI: 10.1002/jat.70154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Applied Toxicology, online erschienen am 24.03.2026. Verfasst von Rohan Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology & Bioengineering, School of Biosciences & Technology, Galgotias University, Greater Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Brain, Drug Delivery Systems, Nanomedicine, Nanotubes, Carbon. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 167 Literaturangaben.
Abstract (Originalsprache)
Neurological and neurodegenerative disorders (NDDs) present ongoing therapeutic challenges attributed to the structural complexity of the central nervous system (CNS) and the restrictive properties of the blood–brain barrier (BBB), which inhibit the effective penetration of most drugs into the brain. Thus, carbon nanotubes (CNTs) possess a high aspect ratio, tunable surface chemistry, and exceptional electrical and mechanical properties, establishing them as versatile nanoplatforms that can address significant challenges in CNS drug delivery. Despite the exploration of various nanocarriers, a significant gap persists in the comprehensive understanding of the convergence of CNT structure, functionalization, mechanistic transport pathways, and safety‐by‐design strategies for translational neurological applications. This review synthesizes recent advancements in CNT engineering, mechanisms of BBB traversal, cell‐specific targeting, and intracellular trafficking, as well as insights into CNT‐induced neurotoxicity and clearance pathways. Further, the review emphasizes therapeutic advancements in CNT‐mediated interventions for Alzheimer's disease ( AD ), Parkinson's disease (PD), brain tumors, stroke, and epilepsy, focusing on multifunctional applications in drug delivery, neuroregeneration, immunomodulation, neuromodulation, theranostic, and biosensing. Additionally, it assesses preclinical results, safety factors, regulatory challenges, and the growing influence of artificial intelligence (AI)‐driven design in enhancing nanoscale behavior, functionalization, and biocompatibility. Lastly, the current review integrates technological innovations with mechanistic toxicology and translational challenges, establishing CNTs as promising neuro‐nanomedicine platforms that may effectively address unmet clinical needs in CNS disorders. Trial Registration: ClinicalTrials.gov: NCT04495634, NCT02873585, NCT01246336, NCT07034248, NCT07034248
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology & Bioengineering, School of Biosciences & Technology, Galgotias University, Greater Noida, Uttar Pradesh, India.
- Department of Physics, School of Basic and Applied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
- Department of Biotechnology, Graphic Era Deemed to Be University, Uttarakhand, India.
ORCID-Profile: Rohan Gupta, Naveen Kumar, Pallavi Singh
Zitieren
APA
Gupta, R., Kumar, R., Kumar, N., & Singh, P. (2026). Reimagining Brain Drug Delivery: Mechanistic and Translational Advances in Carbon Nanotube Nanomedicine. Journal of Applied Toxicology, 46(7), 2250-2274. https://doi.org/10.1002/jat.70154
Vancouver
Gupta R, Kumar R, Kumar N, Singh P. Reimagining Brain Drug Delivery: Mechanistic and Translational Advances in Carbon Nanotube Nanomedicine. Journal of Applied Toxicology. 2026;46(7):2250-2274. doi:10.1002/jat.70154
BibTeX
@article{Gupta2026,
author = {Gupta, Rohan and Kumar, Reetesh and Kumar, Naveen and Singh, Pallavi},
title = {Reimagining Brain Drug Delivery: Mechanistic and Translational Advances in Carbon Nanotube Nanomedicine},
journal = {Journal of Applied Toxicology},
year = {2026},
volume = {46},
number = {7},
pages = {2250--2274},
doi = {10.1002/jat.70154}
}
EUVIMED